Virax Biolabs Group Ltd (NASDAQ:VRAX) price is hovering lower on current market day and dropping -6.29% below its previous close.
A look at today’s price movement shows that the recent level at last check reads $3.19, with intraday deals fluctuating between $2.84 and $3.18. The company’s 5Y monthly beta was ticking 2.051. Taking into account the 52-week price action we note that the stock hit a 52-week high of $9.00 and 52-week low of $0.60. The stock added 157.70% on its value in the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Virax Biolabs Group Ltd, which has a market valuation of $12.97 million, is expected to release its quarterly earnings report in October.
On average, analysts have forecast the company’s revenue for the quarter will hit nan, with the likely lows of nan and highs of nan. Staying with the analyst view, there is a consensus estimate of 10k for the company’s annual revenue in current year.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give VRAX a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy.
The overview shows that VRAX’s price is at present -22.34% off the SMA20 and 33.80% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 46.77, with weekly volatility standing at 16.09%. The indicator jumps to 34.03% when calculated based on the past 30 days. Virax Biolabs Group Ltd (NASDAQ:VRAX)’s beta value is holding at 2.24, while the average true range (ATR) indicator is currently reading 0.94.
An analysis of the Virax Biolabs Group Ltd (NASDAQ:VRAX) stock in terms of its daily trading volume indicates that the 3-month average is 4.34 million. However, this figure increases on the past 10-day timeline to an average of 8.74 million.
Current records show that the company has 4.34M in outstanding shares. The insiders’ percentage holdings are 12.19% of outstanding shares while the percentage share held by institutions stands at 1.63%. The stats also highlight that short interest as of 2024-08-15, stood at 0.26 million shares, which puts the short ratio at the time at 0.68. From this we can glean that short interest is 1273.00 of company’s current outstanding shares. Notably, we see that shares short in August rose slightly given the previous month’s figure stood at 41269.0. But the 104.75% upside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.
